Top 4 Stocks In The Diagnostic Substances Industry With The Highest Profit Margin (TRIB, BLUD, VIVO, QDEL)

Below are the top diagnostic substance stocks on the NYSE and NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech Plc TRIB is 59.32%. TRIB's ROE for the same period is 56.37%. The trailing-twelve-month profit margin at Immucor Inc BLUD is 25.08%. BLUD's PEG ratio is 1.38. The trailing-twelve-month profit margin at Meridian Bioscience Inc VIVO is 20.18%. VIVO had no debt for the latest quarter. The trailing-twelve-month profit margin at Quidel Corporation QDEL is 6.25%. QDEL's revenue for the same period is $148.23 million. Trading Ideas.